Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · February 18, 2024

PSCK9 Inhibitor Use Reduced the Risk of Early Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurology, Neurosurgery, and Psychiatry
PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis
J. Neurol. Neurosurg. Psychiatr. 2024 Jan 11;[EPub Ahead of Print], L Wu, B Zhang, C Li, Z Zhuang, K Liu, H Chen, S Zhu, J Zhu, Z Dai, H Huang, Y Jiang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading